Overview

SMi is proud to present their inaugural conference on Cancer Vaccines. This new and exciting event will bring together senior Pharma representatives and key academics to discuss current developments of cancer immunotherapeutics, engineering vaccine adjuvant formulations, advances and challenges in the advancement of novel therapeutic cancer vaccines and much more.

With presentations from industry representatives from the top 50 pharmaceutical companies, this event promises to be a unique platform for networking, and learning from case studies and problem solving.

Key Benefits of Attending:

Consider novel combination therapies in cancer vaccine development
Understand effective process development strategies
Evaluate developments in cell based immunotherapeutics
Discover strategies to improve success and overcome current issues in clinical
trials
Learn about clinical and regulatory design of immunotherapy programs
Hear from the industry on updates on the most recent successful candidates in
Phase III
Develop monitoring immunotherapy outcomes



Venue: Copthorne Tara Hotel
Location: Kensington, London
Country: United Kingdom

Organiser Contact Details:
SMi Group
T: +44 0 207 827 6194
khalliburton@smi-online.co.uk